Download PDF
Thromb Haemost 1969; 21(03): 524-533
DOI: 10.1055/s-0038-1653566
Originalarbeiten - Original Articles - Travaux Originaux
Schattauer GmbH

The Influence of the Polysaccharide Carrageenin on the Clotting Mechanism of the Blood in the Rabbit in Vitro and in Vivo[*]

K L Schimpf
1   University of Heidelberg, Medical Department (Ludolf -Krehl-Klinik)
,
J Lenhard
1   University of Heidelberg, Medical Department (Ludolf -Krehl-Klinik)
,
G Schaaf
1   University of Heidelberg, Medical Department (Ludolf -Krehl-Klinik)
› Author Affiliations
Further Information

Publication History

Publication Date:
10 June 2018 (online)

    Permissions and Reprints

Summary

Carrageenin is not an antithrombin. It inhibits fibrin aggregation or polymerisation. The inactivation of thrombin by antithrombin and of blood thromboplastin by anti blood thromboplastin is neither accelerated nor retarded. In the presence of Carrageenin the clotting times of tests in which the fibrinpolymerisation phase is involved are lengthened; this simulates a decrease in clotting factors. In vivo Carrageenin, despite its coagulation-inhibitory properties, is not able to reverse the consumption reaction which it has initiated.

* With the aid of a grant from the Deutsche Forschungsgemeinschaft.


 

  • References

  • Egli H, Kessler K, Klesper R. Über die Inaktivierung der Blutthrombokinase (zugleich ein Beitrag zur Unterscheidung von Blut- und Gewebsthrombokinase). Acta haemat. (Basel) 17: 338-354 1957;
    CrossrefPubMedGoogle Scholar
  • Gerendas M. Experimentelle Bestimmung des Thrombininaktivierungsprozesses. Ann. Inst. Biol. Hung 01: 169-182 1949;
    PubMedGoogle Scholar
  • Gerendas M. Die Thrombininaktivierung als Enzymprozeß. Thrombos. Diathes. haemorrh. (Stuttg) 04: 56-70 1960;
    PubMedGoogle Scholar
  • Hausman R, Dreyfus P. M. Intercapillary precipitates produced in rabbits by means of sodium polyanetholsulfonate. Arch. Path. Lab. Med 56: 597-606 1953;
    PubMedGoogle Scholar
  • Hawkins W. S, Leonhard V. G. Antipeptic and antithrombic properties of carrageenin. J. Lab. clin. Med 60: 641-648 1962;
    PubMedGoogle Scholar
  • Hawkins W. W, Leonhard V. G. The antithrombic activity of carrageenin in human blood. Canad. J. Biochem 41: 1325-1327 1963;
    PubMedGoogle Scholar
  • Huth K, Blumenthal J, Mittermayer C, Lasch H. G. Experimentelle Verbrauchskoagulopathie nach Carrageenin. Verh. dtsch. Ges. inn. Med 72: 287-291 1967;
    PubMedGoogle Scholar
  • Jung E. G, Duckert F, s. Jung E. G. A rapid quantitative assay of factor VIII (AHG) without the use of hemophilia A plasma. Thrombos. Diathes. haemorrh. (Stuttg) 04: 323-330 1960;
    PubMedGoogle Scholar
  • Rodriguez-Erdmann F. Über eine einfache Methode zur Blutgewinnung beim Kaninchen. Pflügers Arch. ges. Physiol 269: 306-307 1959;
    CrossrefPubMedGoogle Scholar
  • Rodriguez-Erdmann F, Krecke H-J, Lasch H. G, Bohle A. Über die morphologischen und gerinnungsanalytischen Veränderungen nach Liquoid (Ein Beitrag zur Pathogenese des Sanarelli-Shwartzman-Phänomens). Z. ges. exp. Med 134: 109-130 1960;
    CrossrefPubMedGoogle Scholar
  • Schimpf K. l, Grämlich H, Türk A. Untersuchungen zur Funktion der Anti-Plasmathrombo- kinase. Z. ges. exp. Med 133: 123-134 1960;
    CrossrefPubMedGoogle Scholar
  • Selye H. Induced hypersensitivity to cold. Science 149: 201-202 1965;
    CrossrefPubMedGoogle Scholar
  • Vermylen C, Verstraete M. Différentiation des inhibiteurs de la conversion du fibrinogène en fibrin. Soc. franç. Hématol. Séance du 14.décembre. 1964
    PubMedGoogle Scholar
  • Vermylen G, DeVreker R. A, Verstraete M. A rapid enzymatic method for assay of fibrinogen fibrin polymerisation time (FPT-Test). Clin. chim. Acta 08: 418-425 1963;
    CrossrefPubMedGoogle Scholar